Literature DB >> 21289196

Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring.

José L Moreno1, Mitsumasa Kurita, Terrell Holloway, Javier López, Richard Cadagan, Luis Martínez-Sobrido, Adolfo García-Sastre, Javier González-Maeso.   

Abstract

Epidemiological studies indicate that maternal influenza viral infection increases the risk for schizophrenia in the adult offspring. The serotonin and glutamate systems are suspected in the etiology of schizophrenia, as well as in the mechanism of action of antipsychotic drugs. The effects of hallucinogens, such as psilocybin and mescaline, require the serotonin 5-HT(2A) receptor, and induce schizophrenia-like psychosis in humans. In addition, metabotropic glutamate receptor mGlu(2/3) agonists show promise as a new treatment for schizophrenia. Here, we investigated the level of expression and behavioral function of 5-HT(2A) and mGlu(2) receptors in a mouse model of maternal influenza viral infection. We show that spontaneous locomotor activity is diminished by maternal infection with the mouse-adapted influenza A/WSN/33 (H1N1) virus. The behavioral responses to hallucinogens and glutamate antipsychotics are both affected by maternal exposure to influenza virus, with increased head-twitch response to hallucinogens and diminished antipsychotic-like effect of the glutamate agonist. In frontal cortex of mice born to influenza virus-infected mothers, the 5-HT(2A) receptor is upregulated and the mGlu(2) receptor is downregulated, an alteration that may be involved in the behavioral changes observed. Additionally, we find that the cortical 5-HT(2A) receptor-dependent signaling pathways are significantly altered in the offspring of infected mothers, showing higher c-fos, egr-1, and egr-2 expression in response to the hallucinogenic drug DOI. Identifying a biochemical alteration that parallels the behavioral changes observed in a mouse model of prenatal viral infection may facilitate targeting therapies for treatment and prevention of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21289196      PMCID: PMC3037097          DOI: 10.1523/JNEUROSCI.4230-10.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  81 in total

Review 1.  Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder?

Authors:  Craig M Powell; Tsuyoshi Miyakawa
Journal:  Biol Psychiatry       Date:  2006-06-15       Impact factor: 13.382

2.  Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia.

Authors:  Vicki Babulas; Pam Factor-Litvak; Raymond Goetz; Catherine A Schaefer; Alan S Brown
Journal:  Am J Psychiatry       Date:  2006-05       Impact factor: 18.112

3.  Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis.

Authors:  Thomas H McGlashan; Robert B Zipursky; Diana Perkins; Jean Addington; Tandy Miller; Scott W Woods; Keith A Hawkins; Ralph E Hoffman; Adrian Preda; Irvin Epstein; Donald Addington; Stacy Lindborg; Quynh Trzaskoma; Mauricio Tohen; Alan Breier
Journal:  Am J Psychiatry       Date:  2006-05       Impact factor: 18.112

4.  Characterization of the reconstructed 1918 Spanish influenza pandemic virus.

Authors:  Terrence M Tumpey; Christopher F Basler; Patricia V Aguilar; Hui Zeng; Alicia Solórzano; David E Swayne; Nancy J Cox; Jacqueline M Katz; Jeffery K Taubenberger; Peter Palese; Adolfo García-Sastre
Journal:  Science       Date:  2005-10-07       Impact factor: 47.728

Review 5.  PCP: from pharmacology to modelling schizophrenia.

Authors:  Brian J Morris; Susan M Cochran; Judith A Pratt
Journal:  Curr Opin Pharmacol       Date:  2005-02       Impact factor: 5.547

6.  Prenatal viral infection in mouse causes differential expression of genes in brains of mouse progeny: a potential animal model for schizophrenia and autism.

Authors:  S H Fatemi; D A Pearce; A I Brooks; R W Sidwell
Journal:  Synapse       Date:  2005-08       Impact factor: 2.562

7.  Gene expression changes in brains of mice exposed to a maternal virus infection.

Authors:  Linnéa Asp; Simret Beraki; Fredrik Aronsson; Lina Rosvall; Sven Ove Ogren; Krister Kristensson; Håkan Karlsson
Journal:  Neuroreport       Date:  2005-07-13       Impact factor: 1.837

8.  The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology.

Authors:  Urs Meyer; Myriel Nyffeler; Andrea Engler; Adrian Urwyler; Manfred Schedlowski; Irene Knuesel; Benjamin K Yee; Joram Feldon
Journal:  J Neurosci       Date:  2006-05-03       Impact factor: 6.167

9.  Maternal influenza infection is likely to alter fetal brain development indirectly: the virus is not detected in the fetus.

Authors:  Limin Shi; Nora Tu; Paul H Patterson
Journal:  Int J Dev Neurosci       Date:  2005 Apr-May       Impact factor: 2.457

Review 10.  Influenza: old and new threats.

Authors:  Peter Palese
Journal:  Nat Med       Date:  2004-12       Impact factor: 53.440

View more
  43 in total

1.  Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice.

Authors:  Francesco Matrisciano; Patricia Tueting; Stefania Maccari; Ferdinando Nicoletti; Alessandro Guidotti
Journal:  Neuropsychopharmacology       Date:  2011-11-16       Impact factor: 7.853

2.  Differences in 5-HT2A and mGlu2 Receptor Expression Levels and Repressive Epigenetic Modifications at the 5-HT2A Promoter Region in the Roman Low- (RLA-I) and High- (RHA-I) Avoidance Rat Strains.

Authors:  Luna Fomsgaard; Jose L Moreno; Mario de la Fuente Revenga; Tomasz Brudek; Dea Adamsen; Cristobal Rio-Alamos; Justin Saunders; Anders Bue Klein; Ignasi Oliveras; Toni Cañete; Gloria Blazquez; Adolf Tobeña; Albert Fernandez-Teruel; Javier Gonzalez-Maeso; Susana Aznar
Journal:  Mol Neurobiol       Date:  2017-03-06       Impact factor: 5.590

3.  Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism.

Authors:  Natalia V Malkova; Collin Z Yu; Elaine Y Hsiao; Marlyn J Moore; Paul H Patterson
Journal:  Brain Behav Immun       Date:  2012-01-30       Impact factor: 7.217

Review 4.  All roads lead to inflammation: Is maternal immune activation a common culprit behind environmental factors impacting offspring neural control of breathing?

Authors:  Andrew O Knutson; Jyoti J Watters
Journal:  Respir Physiol Neurobiol       Date:  2019-12-23       Impact factor: 1.931

5.  Investigating the neuroimmunogenic architecture of schizophrenia.

Authors:  R Birnbaum; A E Jaffe; Q Chen; J H Shin; J E Kleinman; T M Hyde; D R Weinberger
Journal:  Mol Psychiatry       Date:  2017-05-09       Impact factor: 15.992

6.  Prenatal immune challenge in rats: altered responses to dopaminergic and glutamatergic agents, prepulse inhibition of acoustic startle, and reduced route-based learning as a function of maternal body weight gain after prenatal exposure to poly IC.

Authors:  Charles V Vorhees; Devon L Graham; Amanda A Braun; Tori L Schaefer; Matthew R Skelton; Neil M Richtand; Michael T Williams
Journal:  Synapse       Date:  2012-05-15       Impact factor: 2.562

7.  Prenatal stress induces schizophrenia-like alterations of serotonin 2A and metabotropic glutamate 2 receptors in the adult offspring: role of maternal immune system.

Authors:  Terrell Holloway; José L Moreno; Adrienne Umali; Vinayak Rayannavar; Georgia E Hodes; Scott J Russo; Javier González-Maeso
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

8.  Chronic postnatal chemogenetic activation of forebrain excitatory neurons evokes persistent changes in mood behavior.

Authors:  Kamal Saba; Sonali S Salvi; Sthitapranjya Pati; Praachi Tiwari; Pratik R Chaudhari; Vijaya Verma; Sourish Mukhopadhyay; Darshana Kapri; Shital Suryavanshi; James P Clement; Anant B Patel; Vidita A Vaidya
Journal:  Elife       Date:  2020-09-21       Impact factor: 8.140

9.  Activation of A1-adenosine receptors promotes leukocyte recruitment to the lung and attenuates acute lung injury in mice infected with influenza A/WSN/33 (H1N1) virus.

Authors:  Famke Aeffner; Parker S Woods; Ian C Davis
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

10.  Early life exposure to the 1918 influenza pandemic and old-age mortality by cause of death.

Authors:  Mikko Myrskylä; Neil K Mehta; Virginia W Chang
Journal:  Am J Public Health       Date:  2013-05-16       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.